Patent · US Active

Methods for in vitro differentiation of Th-17+cells

US8183040B2 · kind B2 · utility

2Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 15, 2009
Grant dateMay 22, 2012
Priority date
Expiry dateMay 26, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to an in vitro method for promoting differentiation and proliferation of human T helper lymphocytes that express IL17 (Th-IL17+ cells).The instant method may be used to generate a population of human T helper lymphocytes that express IL17 (Th-IL17+ cells) in vitro. Methods for screening to identify agents capable of modulating Th-IL17+ cell differentiation are also encompassed by the present invention. Isolated, pure populations of homogeneous Th-IL17+ cells that do not express cellular markers characteristic of Th1, Th2, or Treg cells are also encompassed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.